Grifols Company
A company focused on the research, development, production and commercialization of plasma-derived medicines. They also supply high-quality biological materials for life-science research, clinical trials, and for manufacturing pharmaceutical and diagnostic products. They are also involved in the research, development, production and commercialization of diagnostic products.
Estimated Revenue:
$1B to $10B
Funding Status:
IPO
Industry:
Longevity
Number Of Exists:
2
Technology:
COVID
Founded Date:
1940-01-01
Investor Type:
N/A
Headquarters:
Spain
Employee Number:
10001+
Investment Stage:
N/A